Skip to main content
OpenTrials
Completed

NCT Number: NCT06237686

Clinical Investigation Exploring Two Ostomy Product Prototypes

Two ostomy product prototypes (Test product A and B) will be tested in this investigation.

All subjects will test both Test product A and B, with a minimum of 7 days apart. In total, each subject will be enrolled in the investigation for 8 days +3 days.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Coloplast A/S

Humlebæk, 3050, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has given written informed consent
  • Is at least 18 years of age and has full legal capacity
  • Has had an ileostomy for more than 3 months
  • Has suitable peristomal skin area (assessed by investigator)
  • Is currently using flat SenSura Mio 1-piece or 2-piece
  • Has used flat SenSura Mio 1-piece or 2-piece for at least 14 days
  • Has a stoma size less than 45mm in diameter

Exclusion criteria

  • Is currently receiving or have within the past 60 days received radio- and/or chemotherapy (Low doses radio- and/or chemotherapy (Assessed by Principal Investigator) is allowed. for indications other than cancer)
  • Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g. lotion or spray or systemic steroid (tablet/injection) treatment
  • Is pregnant or breastfeeding
  • Has dermatological problems in the peristomal area (assessed by investigator)
  • Participates in other clinical investigations. Exception: Participation in other Coloplast sponsored clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this protocol
  • Has any known allergies towards ingredients in the investigational device

Treatment and study plan

CP363

Device

All subjects will test both Test product A and B, with a minimum of 7 days apart. In total, each subject will be enrolled in the investigation for 8 days +3 days.

Primary outcomes

  1. Primary Objective

    Time frame: 4 hours

    Test product A and B's ability to swell around the stoma (assessed by photo/video)

Sponsors and collaborators

Lead sponsor

Coloplast A/S

Industry

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Feb 1, 2024
Registry last updated
Jun 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.